Literature DB >> 23859188

Hepatitis C virus screening and management of seroconversions in hemodialysis facilities.

Chukwuma Mbaeyi1, Nicola D Thompson.   

Abstract

Over the past two decades, healthcare-associated exposure has increasingly been proved to be a means of hepatitis C virus (HCV) transmission, especially in hemodialysis facilities. The prevalence of HCV among hemodialysis patients is known to be several times greater than that of the general population of the United States, and chronic HCV infection is associated with significant morbidity and mortality among these patients. During 2008-2011, HCV infection outbreaks were identified in multiple US hemodialysis facilities, resulting in at least 46 new HCV infections among hemodialysis patients. These outbreaks, linked to infection control breaches, also highlight the failure of some facilities to follow established guidelines for routine HCV antibody (anti-HCV) screening and response to new HCV infection among hemodialysis patients. Current national guidelines recommend screening of hemodialysis patients for anti-HCV on facility admission and, for susceptible patients, on a semiannual basis. Here, we seek to underscore the importance of compliance with national recommendations for anti-HCV screening of hemodialysis patients and actions to be taken in the event of possible HCV transmission within a hemodialysis facility. These include general steps to ensure that: hemodialysis patients are routinely screened for anti-HCV to facilitate early detection of new infections; newly infected patients are informed of the change in their HCV status and undergo clinical evaluation; and public health officials are notified of new HCV infections in a timely manner. We then focus on the need to assess infection control practices at the facility, with particular attention given to safe handling of injectable medications, hand hygiene and disinfection practices. In the absence of a vaccine, routine screening and adherence to standard infection control practices will remain the key strategies for preventing HCV transmission in hemodialysis units. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2013        PMID: 23859188      PMCID: PMC4620197          DOI: 10.1111/sdi.12097

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  41 in total

1.  Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients.

Authors:  Gayle Shimokura; Feng Chai; David J Weber; Gregory P Samsa; Guo-Liang Xia; Omana V Nainan; Leslie H Tobler; Michael P Busch; Miriam J Alter
Journal:  Infect Control Hosp Epidemiol       Date:  2011-05       Impact factor: 3.254

Review 2.  Identifying newly acquired cases of hepatitis C using surveillance: a literature review.

Authors:  R Sacks-Davis; C VAN Gemert; I Bergeri; M Stoove; M Hellard
Journal:  Epidemiol Infect       Date:  2012-06-01       Impact factor: 2.451

3.  The disclosure dilemma--large-scale adverse events.

Authors:  Denise M Dudzinski; Philip C Hébert; Mary Beth Foglia; Thomas H Gallagher
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

4.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 5.  US outbreak investigations highlight the need for safe injection practices and basic infection control.

Authors:  Joseph F Perz; Nicola D Thompson; Melissa K Schaefer; Priti R Patel
Journal:  Clin Liver Dis       Date:  2010-02       Impact factor: 6.126

6.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

7.  Recommendations for preventing transmission of infections among chronic hemodialysis patients.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2001-04-27

Review 8.  Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach.

Authors:  Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2012-07-26       Impact factor: 9.079

9.  The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C.

Authors:  G Nunnari; A Montineri; V Portelli; F Savalli; F Fatuzzo; B Cacopardo
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-08       Impact factor: 3.507

10.  Analysis of the virus dynamics model reveals that early treatment of HCV infection may lead to the sustained virological response.

Authors:  Saurabh Gupta; Raghvendra Singh
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

View more
  9 in total

Review 1.  Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.

Authors:  Natasha Silva Constancio; Maria Lucia Gomes Ferraz; Carmen Tzanno Branco Martins; Angiolina Campos Kraychete; Paulo Lisboa Bitencourt; Marcelo Mazza do Nascimento
Journal:  J Bras Nefrol       Date:  2019 Oct-Dec

Review 2.  Prophylactic vaccinations in chronic kidney disease: Current status.

Authors:  Alicja E Grzegorzewska
Journal:  Hum Vaccin Immunother       Date:  2015-04-27       Impact factor: 3.452

3.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 4.  100% Use of Infection Control Procedures in Hemodialysis Facilities: Call to Action.

Authors:  Anitha Vijayan; John M Boyce
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-22       Impact factor: 8.237

Review 5.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Roberto J Carvalho-Filho; Ana Cristina C A Feldner; Antonio Eduardo B Silva; Maria Lucia G Ferraz
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 6.  Infection prevention and the medical director: uncharted territory.

Authors:  Toros Kapoian; Klemens B Meyer; Douglas S Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-20       Impact factor: 8.237

7.  A Large Outbreak of Hepatitis C Virus Infections in a Hemodialysis Clinic.

Authors:  Duc B Nguyen; Jennifer Gutowski; Margherita Ghiselli; Tabitha Cheng; Shadia Bel Hamdounia; Anil Suryaprasad; Fujie Xu; Heather Moulton-Meissner; Tonya Hayden; Joseph C Forbi; Guo-Liang Xia; Matthew J Arduino; Ami Patel; Priti R Patel
Journal:  Infect Control Hosp Epidemiol       Date:  2015-11-17       Impact factor: 3.254

Review 8.  Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis.

Authors:  Nahid Ramezan Ghorbani; Shirin Djalalinia; Mitra Modirian; Zahra Esmaeili Abdar; Morteza Mansourian; Armita Mahdavi Gorabi; Hamid Asayesh; Hossein Ansari; Mehrdad Kazemzadeh Atoofi; Ramin Tajbakhsh; Mehdi Noroozi; Saeid Safiri; Mostafa Qorbani
Journal:  J Res Med Sci       Date:  2017-11-28       Impact factor: 1.852

9.  Clinical practice guideline management of blood borne viruses within the haemodialysis unit.

Authors:  Elizabeth Garthwaite; Veena Reddy; Sam Douthwaite; Simon Lines; Kay Tyerman; James Eccles
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.